Stuart Chaussee & Associates’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-100
Closed -$14K 174
2022
Q1
$14K Buy
+100
New +$13.2K 0.01% 102
2021
Q2
Sell
-136
Closed -$16K 240
2021
Q1
$16K Buy
+136
New +$15.7K 0.01% 100

Other funds holding XLV

Stuart Chaussee & Associates's XLV Position: Q2 2022 in Review

Stuart Chaussee & Associates sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q2 2022, closing a stake of 100 shares — an estimated $14K sold.

Stuart Chaussee & Associates first reported a position in XLV in Q1 2021 and held it in 2 quarters. The position peaked at $16K in Q1 2021. 1,463 funds tracked by Wall St. Rank hold XLV as of Q2 2022.

  • Stuart Chaussee & Associates reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q2 2022 after selling out during the quarter.
  • Stuart Chaussee & Associates sold 100 State Street Health Care Select Sector SPDR ETF shares in Q2 2022, an estimated $14K.
  • Stuart Chaussee & Associates first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2021 and held it in 2 quarters.
  • Stuart Chaussee & Associates's State Street Health Care Select Sector SPDR ETF position peaked at $16K in Q1 2021.
  • 1,463 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2022.

Based on Stuart Chaussee & Associates's 13F filing for Q2 2022, filed 15 Jul 2022.